Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $7.00 Analyst target: $36.50 Upside: 421.43%
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. The company is headquartered in San Francisco, California.
See the full interactive analysis & chart →Informational only — not investment advice.